Manufacturing any medical product, including drugs, is a painstaking, highly regulated, and risky business. The company claims that so-called "compassionate" distribution of this as yet untested drug would slow down the program for getting it into full manufacturing.
Are people so dense that they cannot see that drug companies have practical limitations to what they can accomplish? You can't afford to go into full manufacturing for every drug that appears to have usefulness. You make enough, at high expense, to conduct the trials. If you divert that initial supply of the drug for "compassionate" use, then there is no supply to conduct the clinical trials.
What nefarious object would make more sense than what the company is claiming? Do we delay the testing on behalf of one patient and thus deny thousands later the timely delivery of this drug?
Other nations suffered the consequences of thalidomide. Imagine if we made such consequences the rule rather than the exception.
Put that way, the answer is no. But cynic that I've become, I would want to know that NO ONE has gotten to use the drug. Or if the child could be put on the trial.
An issue of marketing a product and a lengthy approval process. Best practice, morally, would be to keep secret the details of experimental or developmental drugs until they are ready for all. However the reality is companies must market the product before it is available to gain funding, move the stock of the company up and pave the way for FDA approval.